NEW
Font size
WorksheetsCOXAPRIN QUIZ
Total questions: 10
Worksheet time: 5mins
What makes Polmacoxib different from traditional NSAIDs?
It inhibits both COX-1 and COX-2
It selectively inhibits COX-2 in joint tissues only
It blocks all inflammatory pathways
It has no effect on COX enzymes
Why do traditional COX-2 inhibitors (like Etoricoxib) have a black box warning?
They cause severe gastrointestinal bleeding
They increase the risk of heart attacks and strokes
They have poor efficacy in pain relief
They are not widely prescribed
What is the key advantage of Polmacoxib over Etoricoxib?
Lower price
Stronger anti-inflammatory effect
Better cardiovascular safety
Faster pain relief
Who are the Primary Target (A) doctors for Coxaprin?
Doctors who already prescribe Polmacoxib
Doctors prescribing Diclofenac and Aceclofenac
Doctors unaware of Polmacoxib but using Etoricoxib
Pediatricians treating inflammation
Why are physicians managing diabetes and hypertension a key target for Coxaprin?
They frequently prescribe Diclofenac
They have a low patient load
They need safer NSAIDs due to cardiovascular risks
They prescribe only Etoricoxib for pain relief
What is the recommended visit frequency per doctor for effective Coxaprin promotion?
Once a month
Twice a month
Weekly (4 times a month)
Daily
What is the total number of targeted doctors per representative for Coxaprin?
10
20
30
40
What is the punchline of Coxaprin?
Targeted Relief, Maximum Safety
Smart COX-2 Inhibitor with the Principle of Safety
Precision in Pain Management
Beyond NSAIDs – A Step Ahead
What is the tagline of Coxaprin?
Smart COX-2 Inhibitor with the Principle of Safety
Precision in Pain Management
A Next-Gen Tissue-Selective COX-2 Inhibitor Designed for Efficacy and Safety
The Future of Pain Relief
· What is the MRP of Coxaprin (Polmacoxib 2mg) per tablet?
₹16.50
₹17.90
₹16.90
₹18.50
